[1] Wick MR, O'Malley DP. Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis[J]. Semin Diagn Pathol, 2018, 35(1): 61-66. [2] Cahalane AM, Kilcoyne A, Tabari A, et al.Computed tomography texture features can discriminate benign from malignant lymphadenopathy in pediatric patients: a preliminary study[J]. Pediatr Radiol, 2019, 49(6): 737-745. [3] 张昊, 敦铃霞, 谢以婷, 等. 口腔黏膜良性淋巴组织增生病中肥大细胞与微血管的相关性研究[J]. 现代口腔医学杂志, 2019, 33(6): 321-323. [4] Yoshida K, Iwashita T, Uemura S, et al.Efficacy of contrast-enhanced EUS for lymphadenopathy: a prospective multicenter pilot study (with videos)[J]. Gastrointest Endosc, 2019, 90(2): 242-250. [5] Yang LL, Zhang MJ, Wu L, et al.LAIR-1 overexpression and correlation with advanced pathological grade and immune suppressive status in oral squamous cell carcinoma[J]. Head Neck, 2019, 41(4): 1080-1086. [6] Zheng H, Li S.Reduced miRNA-214 expression in oral mucosa contributes to the pathogenesis of oral lichen planus by targeting CD44[J]. Mol Med Rep, 2018, 17(1): 1919-1925. [7] 陈谦明. 口腔黏膜病学[M]. 第4版. 北京: 人民卫生出版社, 2012: 156-158. [8] 夏骏, 刘强, 王兆亮, 等. 免疫组织化学检测Ki-67、 HER-2、 CD44、 CK20在膀胱非浸润性乳头状尿路上皮癌分级中的应用[J]. 临床与实验病理学杂志, 2019, 35(11): 1310-1314. [9] 侯亚丽, 张昊, 郝亚丽, 等. 98例口腔黏膜良性淋巴组织增生病的临床病理分析[J]. 中华口腔医学杂志, 2018, 53(3): 191-194. [10] Mishra MN, Chandavarkar V, Sharma R, et al.Structure, function and role of CD44 in neoplasia[J]. J Oral Maxillofac Pathol, 2019, 23(2): 267-272. [11] Ghazi N, Saghravanian N, Taghi Shakeri M, et al.Evaluation of CD44 and TGF-B expression in oral carcinogenesis[J]. J Dent (Shiraz), 2021, 22(1): 33-40. [12] Kartini D, Taher A, Panigoro SS, et al.Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial[J]. J Egypt Natl Canc Inst, 2020, 32(1): 12-20. [13] Sharma M, Fonseca FP, Hunter KD, et al.Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation[J]. Int J Oral Sci, 2020, 12(1): 23-31. [14] Liu PF, Chen CF, Shu CW, et al.UBE2C is a potential biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma[J]. Diagnostics (Basel), 2020, 10(9): 674-682. [15] Kim MY, Yu KR, Kenderian SS, et al. Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia[J]. Cell, 2018, 173(6): 1439-1453.e19. [16] 熊倩, 刘秋虹, 石玉梅. CD44、CD133在口腔黏膜组织癌变过程中的表达及其意义[J]. 实用预防医学, 2018, 25(12): 1488-1491. [17] 祁佳佳, 孙艳, 袁昌青, 等. CD44和CD133在口腔潜在恶性病变和口腔鳞状细胞癌中的表达及其临床意义[J]. 华西口腔医学杂志, 2017, 35(3): 311-316. [18] 毛煌兴, 刘晓阳, 周晓, 等. CD44过表达与口腔癌患者临床病理特征及生存预后的荟萃分析[J]. 肿瘤药学, 2020, 10(5): 594-599, 607. |